 |
|
|
|
| Sumanth Addanki |
| Senior Vice President |
|
Dr. Addanki specializes in antitrust, intellectual property, and the evaluation of commercial damages. In recent years, he has worked extensively on matters pertaining to the pharmaceutical industry, ranging from antitrust and intellectual property cases to commercial litigation and policy analyses.
In the antitrust area, Dr. Addanki has analyzed the competitive consequences of numerous mergers in a wide range of industries, including agricultural products, chemicals, consumer products, medical devices, pharmaceuticals, and semiconductors, among many others. He has frequently presented the results of his analyses to US antitrust agencies and courts. In addition, he has addressed liability and damages issues in cases alleging predatory pricing, monopolization, resale price maintenance, tying, and other antitrust violations in a variety of different industries.
Many of Dr. Addanki's antitrust inquiries have focused specifically on intellectual property and its unique role in the analysis of market power and competitive effects. In the intellectual property area, more generally, he has evaluated economic damages in cases involving patent infringement, trade secrets, trade dress, and other claims. He has written and lectured extensively on the use of economic analysis in these matters.
Dr. Addanki has testified before state and Federal courts, the US Federal Trade Commission, and various other regulatory bodies. His articles and speeches have been invited and published by the American Bar Association, the Practicing Law Institute, European Competition Law Review, and other comparable institutions.
|
|
 |
|
|
| |
